Pages that link to "Item:Q87467"

The following pages link to Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points (Q87467):

Displaying 26 items.

• surrosurv (Q30016) (← links)
• Assessing the value of a censored surrogate outcome (Q118842) (← links)
• Missing data methods in longitudinal studies: a review (Q619079) (← links)
• On composite marginal likelihoods (Q732228) (← links)
• An information-theoretic approach to surrogate-marker evaluation with failure time endpoints (Q746103) (← links)
• Choice of units of analysis and modeling strategies in multilevel hierarchical models (Q957034) (← links)
• Exploring and validating surrogate endpoints in colorectal cancer (Q1029801) (← links)
• Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614) (← links)
• Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329) (← links)
• Assessing the numerical integration of dynamic prediction formulas using the exact expressions under the joint frailty-copula model (Q2068976) (← links)
• Bayesian ridge estimators based on copula-based joint prior distributions for regression coefficients (Q2095777) (← links)
• Meta-analysis of individual patient data with semi-competing risks under the Weibull joint frailty-copula model (Q2228211) (← links)
• Simplified modeling strategies for surrogate validation with multivariate failure-time data (Q2445595) (← links)
• The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730) (← links)
• Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
• Multivariate frailty models for two types of recurrent events with a dependent terminal event: Application to breast cancer data (Q2857993) (← links)
• Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling (Q2894010) (← links)
• Bayesian Adaptive Trial Design for a Newly Validated Surrogate Endpoint (Q2894012) (← links)
• Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
• Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data (Q5450466) (← links)
• Pairwise Fitting of Mixed Models for the Joint Modeling of Multivariate Longitudinal Profiles (Q5492080) (← links)
• Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints (Q6068471) (← links)
• A joint frailty‐copula model for meta‐analytic validation of failure time surrogate endpoints in clinical trials (Q6071311) (← links)
• Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
• Cluster-robust estimators for multivariate mixed-effects meta-regression (Q6111506) (← links)
• Bayesian ridge regression for survival data based on a vine copula-based prior (Q6120619) (← links)